Cargando…

Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV

INTRODUCTION: People living with HIV (PLHIV) have greater risk of having multiple health conditions. We measured the relationship between increased medication and overall quality of life among PLHIV from 24 countries. METHODS: We analyzed data for 2,112 adult PLHIV on antiretroviral therapy (ART) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okoli, Chinyere, de los Rios, Patricia, Eremin, Anton, Brough, Gary, Young, Benjamin, Short, Duncan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085909/ https://www.ncbi.nlm.nih.gov/pubmed/32134717 http://dx.doi.org/10.5888/pcd17.190359

Ejemplares similares

Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries
por: Okoli, Chinyere, et al.
Publicado: (2021)

Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV
por: Okoli, Chinyere, et al.
Publicado: (2020)

76. Effects of the “Undetectable = Untransmittable” (“U=U”) Educational Campaign on Treatment Outcomes and Perceptions among People Living with HIV in North American Countries
por: Spinelli, Frank, et al.
Publicado: (2021)

Factors Associated with Treatment Satisfaction Among People Living with HIV in Japan and Other Selected Countries: Examination of the Intertwined Roles of Medication, Patient, and Provider Characteristics
por: Koga, Ichiro, et al.
Publicado: (2021)

Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
por: Chen, Shanquan, et al.
Publicado: (2022)

Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
por: de los Rios, Patricia, et al.
Publicado: (2020)

Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
por: de los Rios, Patricia, et al.
Publicado: (2021)

1045. Treatment-Related Physical, Emotional, and Psychosocial Challenges and their Impact on Indicators of Quality of Life
por: Rios, Patricia De Los, et al.
Publicado: (2020)

The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia
por: Yu, Fei, et al.
Publicado: (2022)

What is polypharmacy in people living with HIV/AIDS? A systematic review
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2022)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

1494. Impact of Polypharmacy on Gait Speed and Falls in Older People Living with HIV.
por: Kosana, Priya, et al.
Publicado: (2023)

Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil
por: da Silva, Robson Pierre Nascimento, et al.
Publicado: (2023)

1017. Haves vs. Have-Nots in Healthcare Communication: Examining the Paradox Where PLHIV Who Need Quality Discussions with their Providers the Most, Access it the Least
por: Rios, Patricia De Los, et al.
Publicado: (2020)

POLYPHARMACY IN ASSISTED LIVING
por: Galik, Elizabeth
Publicado: (2022)

Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience
por: KARA, Emre, et al.
Publicado: (2019)

Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
por: Danjuma, Mohammed I., et al.
Publicado: (2022)

936. Evaluating the Impact of Polypharmacy on Virologic Success in People with HIV
por: Jimenez, Humberto R, et al.
Publicado: (2020)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review
por: He, Jiamin, et al.
Publicado: (2023)

Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens
por: Okoli, Chinyere, et al.
Publicado: (2021)

Polypharmacy among HIV infected people aged 50 years or older
por: Fernández Cañabate, Sonia, et al.
Publicado: (2019)

71. Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States
por: Paudel, Misti, et al.
Publicado: (2021)

Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam
por: Thi Bui, Dieu Huyen, et al.
Publicado: (2021)

581. Do Comorbidities and Polypharmacy Lead to Virologic Failure in All Populations Living with HIV?
por: Jimenez, Humberto, et al.
Publicado: (2018)

Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
por: Randles, Mary A., et al.
Publicado: (2022)

Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study
por: Justice, Amy C, et al.
Publicado: (2021)

The Next Therapeutic Challenge in HIV: Polypharmacy
por: Edelman, E. Jennifer, et al.
Publicado: (2013)

The challenge of HIV treatment in an era of polypharmacy
por: Back, David, et al.
Publicado: (2020)

Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south‐east Nigeria
por: Mbachu, Chinyere, et al.
Publicado: (2017)

Factors associated with excessive polypharmacy in older people
por: Walckiers, Denise, et al.
Publicado: (2015)

Patterns and prognosis of holding regimens for people living with HIV in Asian countries
por: Kim, Jung Ho, et al.
Publicado: (2022)

Children Living with HIV-Infected Adults: Estimates for 23 Countries in sub-Saharan Africa
por: Short, Susan E., et al.
Publicado: (2015)

Unravelling factors associated with malaria parasitaemia among children 6–24 months to inform malaria interventions in Nigeria: evidence from 2021 Malaria Indicator Survey
por: Ujuju, Chinazo N., et al.
Publicado: (2023)

Psychometric Validation of the Brazilian Portuguese Version of the Derriford Appearance Scale-24 (DAS-24) for People Living with HIV/AIDS
por: Martins, Marcos Alberto, et al.
Publicado: (2020)

HIV therapy in an ageing population — the challenge of polypharmacy
por: Back, DJ
Publicado: (2010)

Polypharmacy in the HIV-infected older adult population
por: Gleason, Lauren J, et al.
Publicado: (2013)

Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China
por: Zheng, Chunyuan, et al.
Publicado: (2022)

Polypharmacy in the Homebound Population
por: Cook, Erin Atkinson, et al.
Publicado: (2022)

Polypharmacy: A Global Risk Factor for Elderly People
por: Dagli, Rushabh J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vn2jrapqjpvlv5jocii2vtpb18